foto
LATEST NEWS

 OctoPlus announces 2010 first half-year results



WEBCAST HALF-YEAR RESULTS

Click here to access the webcast of 6 August 2010



OCTOPLUS OPENED NYSE EURONEXT

In celebration of OctoPlus' 15 year anniversday, CEO Simon Sturge and CFO Susan Swarte opened the financial markets in Amsterdam on Tuesday 27 July



OCTOPLUS ANNUAL REPORT 2009
VIEW OUR WEB SEMINARS
OCTO SHARE PRICE
HOME dashNL dash CONTACT

 

DOWNLOAD FACTSHEETS

Corporate Information

General information about OctoPlus' history, location, capabilities and activities


OctoPlus Corporate Brochure


OctoDEX

A novel dextran-based microsphere delivery technology for proteins and particulate systems


Factsheet OctoDEX


PolyActive

A biodegradable polymeric drug delivery system for the controlled release of proteins and lipophilic small molecules


Factsheet PolyActive


SynBiosys

A biodegradable polymeric drug delivery system for peptides and small molecules


Factsheet SynBiosys


Formulation Development

General information about OctoPlus' formulation development expertise, liposome formulation and analytical support


Factsheet Formulation Development


Formulation Development of Poorly Soluble Drugs

In-depth information about formulation development for poorly water-soluble drug compounds, liposomes and analytical support


Factsheet Formulation Development of Poorly Soluble Drugs


Formulation Development for Pulmonary Delivery

In-depth information about formulation development with special excipients for pulmonary delivered drug compounds


Factsheet Formulation Development for Pulmonary Delivery


Clinical Manufacturing

Factsheet on our capacities for formulation, manufacturing and freezedrying of clinical study material and small scale commercial material


Factsheet Clinical Manufacturing